4376 results about "Acne" patented technology

Devices and methods for the treatment of skin conditions and lesions are disclosed herein. A compact hand held device that can be safely used by those suffering from skin conditions, such as acne, warts, cold blisters, blemished skin, or fine wrinkles. The devices employ the application of ultrasound energy and heat for the treatment of skin conditions and lesions. Typically, the peak temperatures employed are about 40° C. to about 70° C. by the devices, are achieved in less than about 20 second, and maintained for less than about 40 second. Ultrasound absorption and thermal conduction transfers heat from the device to the skin and causes a biological response that accelerates acne clearing, treats blemished skin, itching, or fine wrinkles. The total heat transferred is low enough to prevent burns.

Methods of treating, preventing, correcting and/or managing skin diseases or disorders characterized by overgrowths of the epidermis, keratoses, scleroderma, cutaneous vasculitis, acne or wrinkles are disclosed. Specific embodiments encompass the administration of an immunomodulatory compound, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent. Specific second active ingredients are capable of affecting or inhibiting cell growth or proliferation, removing or improving acne scars, or reducing or correcting wrinkle lines. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.

An apparatus and method for the phototherapy of different skin conditions, particularly acne vulgaris and seborrhea. The invention transporting compounds, and/or a methylene blue solution. The apparatus includes at least one narrow spectral band light source with spectral emittance concentrated in the violet/blue spectral band and an optical system for controlling spectra and beam parameters of said light source and a mechanical fixture for holding the said light source at an adjustable distance and direction related to the skin treated area, and an electonic unit to control the duration and power and spectral bands of the emitted radiation.

Increased compliance in the use of topical sunscreens is obtained by combining a topical sunscreen agent in a formulation containing an antibacterial medication such as azelaic acid or an antibiotic.

The invention discloses a traditional Chinese medicine for treating acne through oral administration and is prepared by more than fifty traditional Chinese medicinal materials of gamene, broom cypress fruit, cortex dictamni, and so on; moreover, the invention is added with proper amount of pangolin so as to strengthen the effect of pus evacuation. According to the traditional Chinese theory of clearing away heat and toxic material, clearing lung heat, invigorating the spleen, relieving dyspepsia, promoting qi, removing dampness, dispelling wind, arresting itching, strengthening interior, relieving superficies, activating blood circulation, cooling the blood, removing stagnation, dredging the collaterals, resisting bacterium and diminishing inflammation, the invention makes use of the synergetic effect of the components to treat acne. The medicine for oral administration has short treatment course, stable curative effect and no recurrence; mild acne can be cured in about 30 days, moderate acne about 45 days and severe acne about 60 days; through the clinical observation of 100 cases of patients with acne, the effective rate of the invention can be 100 percent and the cure rate thereof can reach 62 percent; therefore the invention solves the problems of long treatment course, insignificant curative effect, easy recurrence and certain side effect on the human body in the existing medicines used for treating acne. .

The invention relates to clear, stable topical compositions of clarithromycin for the treatment of acne and processes for their preparation. The transparent topical compositions include clarithromycin, a zinc salt, a pharmaceutically acceptable vehicle and may include gelling agents.

The invention belongs to the technical field of cosmetics, and in particular relates to a moisturizing essence lotion and a preparation method of the moisturizing essence lotion. The moisturizing essence lotion is prepared from the following components in percentage by weight: 0.00003%-25.5% of sodium hyaluronate, 0.00001%-20% of sodium acetylated hyaluronate, 0.00001%-20% of hydrolyzed hyaluronic acid, 0.001%-1% of a thickener, 0.5%-40% of a moisturizer, 0.1%-30% of a skin efficacy agent, and the balance of deionized water. The essence lotion provided by the invention can regulate the cell viability of the skin essentially, so as to achieve the effects of whitening the skin, resisting wrinkles and resisting skin aging, especially, for the inflammatory skin such as pimple and acne, the moisturizing essence lotion can inhibit the activity of bacteria on the surface of the skin, so that the inflammation can be alleviated.

The invention features a method of treating acne by piercing the stratum corneum of skin in need of such treatment with a stratum corneum-piercing device that contains at least one stratum corneum-piercing microprotrusion and a compressible cover such that the compressible cover substantially encases the at least one stratum corneum-piercing microprotrusion, and wherein upon contacting the skin with the compressible cover, the at least one stratum corneum-piercing microprotrusion protrudes from the compressible cover and pierces the stratum corneum of the skin.

A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.

An antiproliferative, antiinflammatory, antiinfective, immunization agent of a metal ion chelating agent such as picolinic acid, analogs or derivatives thereof, and methods of using the same. The agents chelate metals in metal containing protein complexes and enzymes required for growth, replication or inflammatory response. The preparations can be administered systemically or topically. The products can be used to reduce systemic levels of metals in disease states such as Wilson's disease, iron or lead toxicity. The preparations have antineoplastic, antiviral, antiinflammatory, analgesic antiangiogenic and antiproliferative effects and are used in the treatment of warts, psoriasis, acne, cancers, sunburn, inflammatory responses, untoward angiogenesis and other diseases and in the prevention of sexually transmitted diseases such as genital warts, herpes and AIDS.

A cosmetic treatment method, and a device therefor, are provided that allow for cosmetic treatment of cosmetic disorders, caused by chronological age, environmental factors, changes in physiological functions of skin, such as psoriasis, dermatitis, acne, cellulites, and viral and/or bacteriological attacks. The device comprises a nitric oxide (NO) eluting polymer arranged to contact the area to be cosmetically treated, such that a cosmetic dose of nitric oxide is eluted from said nitric oxide eluting polymer to said area. The nitric oxide (NO) eluting polymer is integrated with a carrier material, such that said carrier material, in use, regulates and controls the elution of said cosmetic dosage of nitric oxide (NO). Furthermore, a manufacturing method for said device is provided.

This invention relates to a stable topical formulation of clarithromycin and its use in the treatment of acne.

The invention discloses an acne-removing scar-lightening mask solution which is prepared from the following components in percentage by weight: 0.01-1% of high-molecular humectant, 0.01-0.2% of disodium edetate, 0.01-0.5% of thickener, 5-25% of witch hazel extract, 0.01-2.0% of conditioner, 0.01-5% of desensitizer, 1-10% of low-molecular humectant, 1-8% of plant acne-removing agent, 0.1-0.5% of preservative, 0.01-0.5% of mung bean extract, 0.01-5% of epidermal growth factor and the balance of deionized water. The manufacturing method of the acne-removing scar-lightening mask solution is simple. Under the synergistic actions of the plant acne-removing agent and mung bean extract in combination with the epidermal growth factor and witch hazel extract, the mask solution has the quick effects of acne removal, itching relief and sterilization, and can restore the damaged skin and lighten the acne marks and scars while removing the acnes, thereby improving the skin from inside to outside and restoring the smooth, delicate and healthy skin.

The present invention is directed to compositions for anti-acne sunscreen. The sunscreen composition has the unique ability to treat and prevent acne in addition to screen both UVA and UVB radiation. In particular, the sunscreen composition includes a sunscreen base, at least one UVA deactivator, at least one UVB deactivator, and at least one anti-acne agent. The UVA deactivator may be avobenzone and the UVB deactivator may be selected from one of the following oxybenzone, octisalate, octyl methoxycinnamate, or a mixture thereof.

An intradermal or transdermal delivery system for topical administration of cosmetic agents, particularly water-soluble, poorly water-soluble, or water-insoluble cosmetic agents, in conjunction with an apparatus that generates micro-channels in the skin of a subject, is useful in treating skin conditions such as cellulite, hyper-pigmentation, skin aging, and acne.

The present invention provides several skin enrichment formulations comprising ubiquinones. The present invention provides a composition for the treatment of acne, topical antimicrobial ointment, sunscreening agents, facial cleansing, reduction of skin inflammation, firming skin tone, cosmetic foundation, skin protection, lip skin protection and skin cream. In a preferred embodiment, the composition contains Coenzyme Q₁₀.

The present invention is directed to skin treatment formulations having salicylic acid and other secondary ingredients. The secondary ingredients may include: non-comedogenic essential oils and plant extracts and sebum reducing agents. Salicylic acid and the secondary ingredients are provided in amounts effective to provide a sufficiently aggressive skin treatment for unclogging pores and reducing inflammation, while maintaining levels of sebum on the exterior of the skin to form an operative water barrier on the skin and hair. Additionally, a method is provided that unclogs pores, reduces inflammation, and controls levels of sebum on the exterior of the skin to maintain an operative water barrier on the skin and hair. The method may include, applying a sufficiently aggressive product comprising salicylic acid, non-comedogenic plant extracts and essential oils, and a sebum reducing agent to hair and its surrounding areas.

The present invention provides novel methods and materials including for treating acne and including methods comprising administering to a subject a composition comprising a therapeutically effective amount of XMP.629 or a pharmaceutically acceptable salt or derivative thereof.